Thus, ER/PR-positive cells (MCF-7, BT-474, and ZR-75-1) were used to evaluate the specific sensitivity of p(ERE)2-(PRE)2FLuc to the steroid receptors, while triple-negative breast cancer cells (MDA-MB-231) were employed as the control group. This evidence concerns the gene PGR and triple-negative breast carcinoma.